Matches in Wikidata for { <http://www.wikidata.org/entity/Q61938016> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q61938016 description "assaig clínic" @default.
- Q61938016 description "clinical trial" @default.
- Q61938016 description "clinical trial" @default.
- Q61938016 description "clinical trial" @default.
- Q61938016 description "clinical trial" @default.
- Q61938016 description "ensaio clínico" @default.
- Q61938016 description "ensayo clínico" @default.
- Q61938016 description "ensayu clínicu" @default.
- Q61938016 description "essai clinique" @default.
- Q61938016 description "klinisch onderzoek" @default.
- Q61938016 description "клінічне випробування" @default.
- Q61938016 name "An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients" @default.
- Q61938016 type Item @default.
- Q61938016 label "An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients" @default.
- Q61938016 prefLabel "An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients" @default.
- Q61938016 P1050 Q61938016-5F97D787-1CB3-4B7E-AA23-12A5FA2C5CC3 @default.
- Q61938016 P1132 Q61938016-84BAB17D-F4EE-40E1-A802-1D7CC3DB34AB @default.
- Q61938016 P1476 Q61938016-C1D4BB0F-4371-462F-8317-8D5E98B91D74 @default.
- Q61938016 P1813 Q61938016-61DB77D8-A257-4008-BF9F-EACFBE3638DF @default.
- Q61938016 P2899 Q61938016-7498E911-EB77-4B2B-8992-EB5BF238518D @default.
- Q61938016 P3098 Q61938016-9A635B1D-2E16-427E-BA80-7BC7E4C9B117 @default.
- Q61938016 P31 Q61938016-1332F743-D702-439C-8A10-3D9AF0F6B4D2 @default.
- Q61938016 P4844 Q61938016-9004DA37-6FF8-47F9-BC84-8DF30AE9EE9C @default.
- Q61938016 P580 Q61938016-9ADC2C3B-F66B-4B04-B5C8-C8B6C75FFFF5 @default.
- Q61938016 P582 Q61938016-9BACE9B4-BDBA-4494-B6B5-6772CD42658A @default.
- Q61938016 P8363 Q61938016-E9CBA144-30F0-4A8D-9E89-895125CB142F @default.
- Q61938016 P1050 Q12206 @default.
- Q61938016 P1132 "+2033" @default.
- Q61938016 P1476 "The Clinical Safety and Effectiveness of Repaglinide in Treatment-naive Type 2 Diabetes Subjects in China. A 16-week Multicentre, Prospective, Open Label, Non-interventional Study." @default.
- Q61938016 P1813 "SAFE" @default.
- Q61938016 P2899 "+18" @default.
- Q61938016 P3098 "NCT01077570" @default.
- Q61938016 P31 Q30612 @default.
- Q61938016 P4844 Q2195995 @default.
- Q61938016 P580 "2010-03-01T00:00:00Z" @default.
- Q61938016 P582 "2011-02-01T00:00:00Z" @default.
- Q61938016 P8363 Q818574 @default.